¥ 8207
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Undervalued vs peers
About
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, reasonably priced on P/FCF
Target Price
The average target price of 4578.T is 9364 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
